Brief: SK Biopharmaceuticals Co Q1 Preliminary Operating Profit 89.8 Billion Won Up 249.7% Y/Y
07/05/2026 03:16
May 7 (Reuters) - SK Biopharmaceuticals Co Ltd 326030.KS: SK BIOPHARMACEUTICALS CO: Q1 PRELIMINARY OPERATING PROFIT 89.8 BILLION WON UP 249.7% Y/Y Source text: [ID:] Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker